Get the Stockscreener App
0.37
0.01%
+0.000050
After Hours:
.3887
0.0187
+5.05%
Kazia Therapeutics Limited ADR Stock (KZIA) Forecast
The Kazia Therapeutics Limited ADR (KZIA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.6891, representing a +356.50% increase from the current price of $0.37. The highest analyst price target is $2.0214, and the lowest is $1.3567.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month KZIA Price Target
Average 4.3856
(+1,085% Upside)
Is Kazia Therapeutics Limited ADR (KZIA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 55.11 | Neutral |
| STOCH(9,6) | 70.56 | Neutral |
| STOCHRSI(14) | 28.77 | Neutral |
| MACD(12,26) | 0.0199 | Sell |
| ADX(14) | 22.37 | Neutral |
| William %R | -51.61 | Neutral |
| CCI(14) | 3.2095 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.3565
Buy
|
0.3681
Buy
|
| MA20 |
0.3635
Buy
|
0.3536
Buy
|
| MA50 |
0.3058
Buy
|
0.3362
Buy
|
| MA100 |
0.3353
Buy
|
0.3918
Sell
|
| MA200 |
0.5886
Sell
|
0.5424
Sell
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, KZIA could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 4 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on KZIA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 55.11 indicates that KZIA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 70.56 indicates that KZIA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 28.77 indicates that KZIA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.37 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 3.2095 indicates that KZIA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term KZIA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Kazia Therapeutics Limited ADR financial reports and earnings history, Kazia Therapeutics Limited ADR (KZIA) stock could reach $0.1794 by 2030, $0.7209 by 2040 and $3.7479 by 2050. See the projected annual prices until 2050 of the Kazia Therapeutics Limited ADR stock below:
- Kazia Therapeutics Limited ADR (KZIA) is expected to reach an average price of $0.1769 in 2035, with a high prediction of $0.2825 and a low estimate of $0.0725. This indicates an $-52.18% rise from the last recorded price of $0.37.
- Kazia Therapeutics Limited ADR (KZIA) stock is projected to chart a bullish course in 2040, with an average price target of $0.6719, representing an $81.60% surge from its current level. The forecast ranges from a conservative $0.6686 to a sky-high $0.7209.
- Our analysts predict Kazia Therapeutics Limited ADR (KZIA) to jump 263.37% by 2045, soaring from $1.3254 to an average price of $1.3445, potentially reaching $1.1845. While $1.3254 is the low estimate, the potential upside is significant.
- Kazia Therapeutics Limited ADR (KZIA) stock is expected to climb by 2050, reaching an average of $2.124, a $474.06% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.7479 and $1.5133, respectively, highlighting the market's uncertainty.
Kazia Therapeutics Limited ADR Stock (KZIA) Year by Year Forecast
Kazia Therapeutics Limited ADR Stock (KZIA) Price Forecast for 2024
Our forecast for KZIA stock price in 2024 now indicates an average price target of $1.4105 with a high forecast of $2.521 and a low forecast of $0.3001. The average prediction reflects an increase of +281.22% from the last recorded price of $0.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $1.4297 | $1.3567 | $2.0214 | +286.40% |
| June, 2024 | $1.237 | $1.2017 | $1.5717 | +234.32% |
| July, 2024 | $0.9124 | $0.5722 | $1.4971 | +146.58% |
| August, 2024 | $1.1327 | $0.7526 | $1.2974 | +206.12% |
| September, 2024 | $0.718 | $0.678 | $0.9806 | +94.06% |
| October, 2024 | $2.1883 | $0.6331 | $2.3583 | +491.44% |
| November, 2024 | $1.5806 | $1.4586 | $2.3034 | +327.20% |
| December, 2024 | $1.634 | $1.204 | $2.0289 | +341.63% |
Kazia Therapeutics Limited ADR Stock (KZIA) Price Forecast for 2025
Kazia Therapeutics Limited ADR Stock (KZIA) is expected to reach an average price of $4.6273 in 2025, with a high prediction of $8.1991 and a low estimate of $1.0555. This indicates an +1,151% rise from the last recorded price of $0.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.8743 | $1.7291 | $8.1991 | +676.84% |
| February, 2025 | $2.9142 | $2.5694 | $3.0445 | +687.63% |
| March, 2025 | $2.85 | $2.3649 | $3.4797 | +670.27% |
| April, 2025 | $2.8516 | $2.4173 | $2.8878 | +670.71% |
| May, 2025 | $1.4606 | $1.0555 | $2.6953 | +294.76% |
| June, 2025 | $1.526 | $1.0657 | $2.2408 | +312.43% |
| July, 2025 | $1.3563 | $1.1012 | $1.9012 | +266.57% |
| August, 2025 | $1.8966 | $1.2814 | $2.0964 | +412.59% |
| September, 2025 | $2.472 | $1.7918 | $3.592 | +568.10% |
| October, 2025 | $4.6023 | $2.3671 | $6.8572 | +1,144% |
| November, 2025 | $6.0426 | $4.1774 | $7.2226 | +1,533% |
| December, 2025 | $4.918 | $4.718 | $6.0666 | +1,229% |
Kazia Therapeutics Limited ADR Stock (KZIA) Price Forecast for 2026
The predicted value for Kazia Therapeutics Limited ADR (KZIA) in 2026 is set at an average of $9.4459. Estimates vary from a peak of $14.60 to a trough of $4.2883, indicating an +2,453% surge from the present price of $0.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.6283 | $4.2883 | $5.263 | +1,151% |
| February, 2026 | $8.9386 | $4.3133 | $14.60 | +2,316% |
| March, 2026 | $7.814 | $7.5789 | $9.6138 | +2,012% |
| April, 2026 | $9.2943 | $7.269 | $11.49 | +2,412% |
| May, 2026 | $10.52 | $8.1145 | $11.09 | +2,744% |
| June, 2026 | $9.9699 | $7.3447 | $12.06 | +2,595% |
| July, 2026 | $10.20 | $9.8202 | $13.76 | +2,657% |
| August, 2026 | $8.0756 | $7.9906 | $11.01 | +2,083% |
| September, 2026 | $9.2159 | $7.9007 | $10.85 | +2,391% |
| October, 2026 | $8.5362 | $8.321 | $9.2009 | +2,207% |
| November, 2026 | $8.4616 | $7.5716 | $8.7312 | +2,187% |
| December, 2026 | $9.3821 | $7.8167 | $9.9768 | +2,436% |
Kazia Therapeutics Limited ADR Stock (KZIA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Kazia Therapeutics Limited ADR (KZIA) is $7.059, with a high forecast of $11.31 and a low forecast of $2.8053. This indicates an +1,808% increase from the last price of $0.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $10.32 | $8.997 | $10.99 | +2,690% |
| February, 2027 | $9.7625 | $8.5174 | $10.70 | +2,539% |
| March, 2027 | $8.9479 | $8.9479 | $11.31 | +2,318% |
| April, 2027 | $6.6667 | $5.9532 | $9.758 | +1,702% |
| May, 2027 | $6.0856 | $5.9637 | $7.9783 | +1,545% |
| June, 2027 | $6.6239 | $5.1187 | $7.0924 | +1,690% |
| July, 2027 | $5.6842 | $5.4042 | $7.099 | +1,436% |
| August, 2027 | $7.1696 | $4.9343 | $7.6144 | +1,838% |
| September, 2027 | $5.6099 | $5.2299 | $7.7746 | +1,416% |
| October, 2027 | $5.2802 | $4.20 | $6.1702 | +1,327% |
| November, 2027 | $3.4555 | $3.3355 | $5.6005 | +833.93% |
| December, 2027 | $2.9759 | $2.8053 | $3.9908 | +704.28% |
Kazia Therapeutics Limited ADR Stock (KZIA) Price Forecast for 2028
In 2028, Kazia Therapeutics Limited ADR (KZIA) is projected to reach an average price of $1.6153, with a high projection of $3.2246 and a low estimate of $0.00601. This indicates an +336.57% rise from the last price of $0.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.9312 | $0.7812 | $3.2246 | +151.68% |
| February, 2028 | $0.8015 | $0.6514 | $1.0663 | +116.63% |
| March, 2028 | $0.3768 | $0.3417 | $0.8966 | +1.85% |
| April, 2028 | $0.1584 | $0.1221 | $0.6471 | -57.18% |
| May, 2028 | $0.0389 | $0.00601 | $0.1951 | -89.49% |
| June, 2028 | $0.0778 | $0.0295 | $0.0323 | -78.98% |
| July, 2028 | $0.4032 | $0.0332 | $0.4532 | +8.97% |
| August, 2028 | $0.2985 | $0.2786 | $0.4583 | -19.32% |
| September, 2028 | $0.4438 | $0.2599 | $0.6387 | +19.95% |
| October, 2028 | $0.7892 | $0.2973 | $0.8492 | +113.29% |
| November, 2028 | $0.8395 | $0.6095 | $1.1543 | +126.89% |
| December, 2028 | $0.7198 | $0.5696 | $0.8845 | +94.54% |
Kazia Therapeutics Limited ADR Stock (KZIA) Price Forecast for 2029
The 2029 price forecast for Kazia Therapeutics Limited ADR Stock (KZIA) is $0.6035 on average, with a high prediction of $1.1898 and a low estimate of $0.0171. This represents an +63.11% increase from the previous price of $0.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.6152 | $0.5053 | $0.8549 | +66.26% |
| February, 2029 | $0.5655 | $0.3553 | $0.6455 | +52.83% |
| March, 2029 | $0.4268 | $0.4227 | $0.6606 | +15.35% |
| April, 2029 | $0.6312 | $0.4319 | $0.741 | +70.58% |
| May, 2029 | $0.2603 | $0.2025 | $0.6762 | -29.66% |
| June, 2029 | $0.2818 | $0.0367 | $0.412 | -23.85% |
| July, 2029 | $0.0671 | $0.0171 | $0.5252 | -81.85% |
| August, 2029 | $1.1898 | $0.038 | $1.1898 | +221.58% |
| September, 2029 | $0.2292 | $0.7392 | $1.1795 | -38.04% |
| October, 2029 | $0.0785 | $0.2089 | $0.4309 | -78.79% |
| November, 2029 | $0.1932 | $0.0318 | $0.772 | -47.78% |
| December, 2029 | $0.2071 | $0.0775 | $0.6823 | -44.02% |
Kazia Therapeutics Limited ADR Stock (KZIA) Price Forecast for 2030
Kazia Therapeutics Limited ADR Stock (KZIA) is expected to reach an average price of $3.3374 in 2030, with a high forecast of $6.6582 and a low forecast of $0.0167. This signifies an +802.01% surge from the last price of $0.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.3465 | $0.1868 | $0.1794 | -6.35% |
| February, 2030 | $0.5073 | $0.4461 | $0.2592 | +37.11% |
| March, 2030 | $0.7453 | $0.7058 | $0.7204 | +101.43% |
| April, 2030 | $0.7145 | $0.6747 | $0.6516 | +93.12% |
| May, 2030 | $0.8939 | $0.9141 | $0.8939 | +141.60% |
| June, 2030 | $0.5967 | $0.0167 | $0.7667 | +61.26% |
| July, 2030 | $0.0574 | $0.037 | $0.7168 | -84.48% |
| August, 2030 | $0.088 | $0.0215 | $0.4779 | -76.21% |
| September, 2030 | $1.1188 | $0.1882 | $6.6582 | +202.38% |
| October, 2030 | $1.5594 | $1.059 | $1.9794 | +321.46% |
| November, 2030 | $1.37 | $0.8799 | $1.7809 | +270.27% |
| December, 2030 | $0.9908 | $0.5908 | $1.4281 | +167.78% |
1.53%
3.38%
Cap:
|
Volume (24h):